REBIF for Secondary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where REBIF was used for Secondary progressive multiple sclerosis.
Most Reported Side Effects for REBIF
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple sclerosis relapse | 158 | 9.0% | 3 | 99 |
| Injection site erythema | 137 | 7.8% | 1 | 26 |
| Influenza like illness | 128 | 7.3% | 2 | 23 |
| Fatigue | 123 | 7.0% | 1 | 45 |
| Injection site pain | 105 | 6.0% | 1 | 22 |
| Headache | 96 | 5.5% | 2 | 26 |
| Injection site bruising | 74 | 4.2% | 0 | 16 |
| Pyrexia | 74 | 4.2% | 5 | 33 |
| Fall | 73 | 4.2% | 2 | 36 |
| Pneumonia | 69 | 4.0% | 12 | 42 |
| Urinary tract infection | 69 | 4.0% | 8 | 46 |
| Depression | 65 | 3.7% | 3 | 22 |
| Pain | 63 | 3.6% | 0 | 23 |
| Hypertension | 61 | 3.5% | 1 | 28 |
| Malaise | 61 | 3.5% | 2 | 30 |
Other Indications for REBIF
Multiple sclerosis (989)
Product used for unknown indication (516)
Relapsing-remitting multiple sclerosis (207)
Other Drugs Used for Secondary progressive multiple sclerosis
SIPONIMOD (2,265)
OCRELIZUMAB (1,273)
OFATUMUMAB (1,099)
FINGOLIMOD (351)
INTERFERON BETA-1B (146)
RITUXIMAB (131)
NATALIZUMAB (115)
DIMETHYL (96)
INTERFERON BETA-1A (89)
RABEPRAZOLE (86)